...
首页> 外文期刊>Trends in Neurosciences >Orphanin FQociceptin: a role in pain and analgesia, but so much more.
【24h】

Orphanin FQociceptin: a role in pain and analgesia, but so much more.

机译:Orphanin FQ / nociceptin:在疼痛和镇痛中起作用,但作用更多。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The publication of the delta opioid receptor sequence led to the cloning of three homologous receptors: the mu and kappa opioid receptors, and a novel opioid-like orphan receptor. The orphan receptor's endogenous ligand, a 17-amino-acid peptide that resembles dynorphin, was named 'orphanin FQ' and 'nociceptin' (OFQ/N1-17).The OFQ/N1-17 receptor is expressed widely in the nervous system, and it is becoming clear that the peptide is likely to participate in a broad range of physiological and behavioral functions.At the cellular level, OFQ/N1-17 has much in common with the classical opioids; however, functional studies are now revealing distinct actions of this peptide. Identified only two years ago, OFQ/N1-17 has already attracted a great deal of attention. The number and diversity of papers focused on OFQ/N1-17 at the recent meeting of the Society for Neuroscience augur an exciting future for this new peptide.
机译:δ阿片受体序列的发布导致了三种同源受体的克隆:mu和kappa阿片受体,以及一种新型阿片样孤儿受体。孤儿受体的内源性配体是一种类似于强啡肽的17个氨基酸的肽,被称为“孤儿蛋白FQ”和“伤害受体”(OFQ / N1-17)。OFQ/ N1-17受体在神经系统中广泛表达在细胞水平上,OFQ / N1-17与经典阿片类药物有很多共同点;在细胞水平上,OFQ / N1-17具有许多共同点。然而,功能研究现在揭示了该肽的独特作用。仅在两年前确定的OFQ / N1-17已经引起了很多关注。在神经科学协会最近的会议上,针对OFQ / N1-17的论文数量众多且种类繁多,预示着这种新肽的发展前景令人振奋。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号